Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for MICRO-TAG with the United States Patent and Trademark Office. The USPTO has given the MICRO-TAG trademark a serial number of 98746046. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 11, 2024. This trademark is owned by NERD BIO, LLC. The MICRO-TAG trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Reagents forming a fluorescence-emitting enzyme complementation system for research use; reagents for real-time cellular target engagement assay systems for research use; reagents for therapeutics discovery assays systems using DNA-encoded libraries for for research use; chemical preparations for use in science other than for medical or veterinary use; biochemicals for in vitro and in vivo [ for ] scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents scientific use; reagents for scientific purposes; [ chemical ] substances, namely, chemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; [ chemical ] substances, namely, chemicals for scientific use; enzymes for scientific purposes; enzymes, othe...
Research and development services in the field of cellular target engagement, discovery and testing of therapeutics; pharmaceutical drug discovery and development services; research and development in the field of therapeutics discovery; research and development in the field of challenging therapeutic targets; research and development of therapeutics for the treatment of various diseases including cancer; technical research in the field of therapeutics; technology research in the field of challenging therapeutic targets; conducting early evaluations in the field of new therapeutics; pharmaceutical products development of new therapeutic molecules belong to the class of small molecules, molecular glues, degraders, peptides and antibodies; pharmaceutical products development of new therapeutic molecules aimed at inhibiting, degrading or modifying disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorde...
